Ad
related to: generic drug companies
Search results
This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream
Motley Fool via Yahoo Finance· 2 days agoMore ups than downs ahead The main patents that protect market exclusivity generally last just 25...
Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Reve
Guru Focus· 9 hours agoVanda Pharmaceuticals Inc (VNDA, Financial) disclosed its financial outcomes for the first quarter of 2024 on May 8, 2024, through its 8-K filing. The company, known for its ...
Earnings call: Assertio Holdings reports growth and CEO search progress
Investing.com· 4 days agoThe company highlighted a significant 32% quarter-over-quarter growth in Rolvedon sales and the...
Earnings call: Xenon Pharmaceuticals reports on Q1 2024 progress By Investing.com
Investing.com· 8 hours agocompany, provided updates on its financial status and clinical program developments during its First...
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 2 days agoDr. Reddy’s operates through three segments: • Global Generics – This segment consists of unbranded...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters· 1 day ago, opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months of 2024. In the wake of February's U.S. Food ...
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
Zacks via Yahoo Finance· 4 days agoThis, in turn, prompts collaboration deals with either pharma or biotech bigwigs, wherein sales are...
Amneal Pharmaceuticals Inc (AMRX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
GuruFocus.com via Yahoo Finance· 7 days agoExpansion in international markets, particularly in India... Points Price erosion in the United States generic industry, although lower than previous years, continues to be ...
Earnings call: Lisata Therapeutics reports Q1 progress on cancer drug
Investing.com· 23 hours agoLisata Therapeutics (ticker not provided) has reported significant advancements in its first quarter...
Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
Barrons.com· 2 days agoShares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company...
